Effect of oral colchicine on T cell subsets, monocytes and concanavalin A‐induced suppressor cell function in asthmatic patients
暂无分享,去创建一个
A. Mazar | S. Spitzer | N. Trainin | M. Garty | L. Netzer | G. Fink | D. Ilfeld | M. Pecht | O. Kuperman
[1] A. Kagey‐Sobotka,et al. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. , 1986, Journal of immunology.
[2] J. Warner,et al. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. , 1986, Journal of immunology.
[3] M. Chan-yeung,et al. Lymphocyte sub‐populations in patients with allergic and non‐allergic asthma , 1985, Clinical allergy.
[4] M. Topilsky,et al. Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients. , 1985, Clinical and experimental immunology.
[5] M. Schuyler,et al. Atopic asthma: T lymphocyte subpopulations , 1985, Clinical allergy.
[6] K. Melmon,et al. Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells. , 1985, The Journal of clinical investigation.
[7] Sudhir Gupta,et al. Deficient Concanavalin‐A‐induced suppressor‐cell activity in patients with bronchial asthma, allergic rhinitis and atopic dermatitis , 1985, Clinical allergy.
[8] M. Topilsky,et al. Effect of colchicine on T cell subsets of healthy volunteers. , 1984, Immunology.
[9] M. Chan-yeung,et al. Lymphocyte Subpopulations in Patients with Allergic Rhinitis , 1984, Allergy.
[10] P. Sierra,et al. T cell subsets in allergic respiratory disease using monoclonal antibodies. , 1984, Annals of allergy.
[11] G. Delpré,et al. In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine. , 1984, Clinical and experimental immunology.
[12] K. Hsieh. Changes of lymphoproliferative responses of T cell subsets to allergen and mitogen after hyposensitization in asthmatic children. , 1984, The Journal of allergy and clinical immunology.
[13] R. Rocklin,et al. Reduced production of histamine-induced suppressor factor (HSF) by atopic mononuclear cells and decreased prostaglandin E2 output by HSF-stimulated atopic monocytes. , 1983, The Journal of allergy and clinical immunology.
[14] Z. Handzel,et al. Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever. , 1983, Clinical and experimental immunology.
[15] M. Pras,et al. The immune system in familial Mediterranean fever. , 1983, Clinical and experimental immunology.
[16] B. Volovitz,et al. Induction of suppressor T cells in asthmatic children by theophylline treatment , 1983, Clinical allergy.
[17] D. Ilfeld,et al. Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine. , 1982, Clinical and experimental immunology.
[18] C. Dinarello,et al. Human monocyte-derived soluble product(s) has an accessory function in the generation of histamine- and concanavalin A-induced suppressor T cells. , 1982, The Journal of clinical investigation.
[19] N. Soter,et al. Abnormal histamine-induced suppressor-cell function in atopic subjects. , 1982, The New England journal of medicine.
[20] S. Smith‐Gill,et al. Enhanced cAMP production by activated human Fc-IgG receptor positive T-cell subpopulations. , 1981, Clinical immunology and immunopathology.
[21] Hsieh Kh. Increased adherent suppressor cell activity in allergic children. , 1981 .
[22] S. Freier,et al. Suppressor T‐lymphocyte activity in wheezy children with and without treatment by hyposensitization , 1981, Clinical allergy.
[23] J. Salvaggio,et al. A comparison of cell‐mediated immunity and suppressor T‐cell function in asthmatic and normal children , 1980, Clinical allergy.
[24] J. Shelhamer,et al. Abnormal beta adrenergic responsiveness in allergic subjects: analysis of isoproterenol-induced cardiovascular and plasma cyclic adenosine monophosphate responses. , 1980, The Journal of allergy and clinical immunology.
[25] D. Stechschulte,et al. Nonspecific suppressor cell function in atopic subjects. , 1979, The Journal of allergy and clinical immunology.
[26] L. Simchowitz,et al. Mechanism of action of colchicine in acute urate crystal-induced arthritis. , 1979, The Journal of clinical investigation.
[27] P. Greengard,et al. Effects of colchicine on cyclic AMP levels in human leukocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[28] K. Resch,et al. Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine. , 1977, Journal of immunology.
[29] Y. Chang,et al. Mechanism of action of colchicine. I. Effect of colchicine and its analogs on the reversed passive Arthus reaction and the carrageenan-induced hindpaw edema in the rat. , 1975, The Journal of pharmacology and experimental therapeutics.
[30] Y. Chang. Mechanism of action of colchicine. II. Effects of colchicine and its analogs on phagocytosis and chemotaxis in vitro. , 1975, The Journal of pharmacology and experimental therapeutics.
[31] E. Middleton,et al. Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. , 1972, The Journal of allergy and clinical immunology.
[32] K. Hsieh. Increased adherent suppressor cell activity in allergic children. , 1981, Annals of allergy.
[33] M. Rola-Pleszczynski,et al. Suppressor cell function in respiratory allergy. Modulation by aminophylline and isoproterenol. , 1981, International archives of allergy and applied immunology.
[34] J. W. Smith,et al. Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. , 1973, The Journal of clinical investigation.
[35] W. PARxE,et al. Alterations in Cyclic Adenosine Monophosphate Metabolism in Human Bronchial Asthma , 2022 .